This inventor holds 12 USPTO granted patents. Top assignees: Pharmacopeia Drug Discovery, Inc., Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2005-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wayne, PA (US) (2012)
- Princeton, NJ (US) (2005 - 2014)
Company Filing History:
6 out of 52 
6 out of 1,829 
4 out of 2,405 
Years Active: 2005-2014
Title: Rachael Catherine Hunter: Innovator in Pharmaceutical Research
Introduction
Rachael Catherine Hunter, located in Princeton, NJ, is a distinguished inventor with a remarkable portfolio of 12 patents. Her innovative work prominently focuses on the development of pharmaceutical compounds aimed at treating various diseases. Rachael's contributions have significantly advanced the field, particularly through her latest patents.
Latest Patents
Rachael's most recent inventions pertain to heterocyclic aspartyl protease inhibitors. These patents disclose compounds characterized by a specific formula, including their stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates. She has categorized methods for inhibiting aspartyl protease, which are particularly geared towards treating cardiovascular diseases, cognitive and neurodegenerative disorders. Furthermore, Rachael's research includes methods aimed at inhibiting the Human Immunodeficiency Virus, plasmepins, cathepsin D, and protozoal enzymes. Notably, her work also explores treating cognitive and neurodegenerative diseases with her compounds in combination with cholinesterase inhibitors or muscarinic agonists or antagonists.
Career Highlights
Rachael has garnered vast experience throughout her career by working with esteemed organizations such as Schering Corporation and Pharmacopeia Drug Discovery, Inc. Her extensive research pursuits have enabled her to hold a significant position in the pharmaceutical innovation landscape.
Collaborations
Throughout her career, Rachael has had the opportunity to collaborate closely with talented individuals, including Tao Guo and William J Greenlee. Their joint efforts have contributed to the advancement of research and development in her field.
Conclusion
Rachael Catherine Hunter's dedication to innovation in pharmaceutical research is evident through her numerous patents and impactful collaborations. Her work continues to pave the way for advancements in treatments for critical health conditions, demonstrating the profound impact of her contributions to the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile